These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18603026)
1. Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. Rivera-Ch M; Huicho L; Bouchet P; Richalet JP; León-Velarde F Respir Physiol Neurobiol; 2008 Aug; 162(3):184-9. PubMed ID: 18603026 [TBL] [Abstract][Full Text] [Related]
2. Selected contribution: Ventilatory response to CO2 in high-altitude natives and patients with chronic mountain sickness. Fatemian M; Gamboa A; Léon-Velarde F; Rivera-Ch M; Palacios JA; Robbins PA J Appl Physiol (1985); 2003 Mar; 94(3):1279-87; discussion 1253-4. PubMed ID: 12571150 [TBL] [Abstract][Full Text] [Related]
3. The effects of acetazolamide on the ventilatory response to high altitude hypoxia. Burki NK; Khan SA; Hameed MA Chest; 1992 Mar; 101(3):736-41. PubMed ID: 1541140 [TBL] [Abstract][Full Text] [Related]
4. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease). Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395 [TBL] [Abstract][Full Text] [Related]
5. Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions. Garske LA; Brown MG; Morrison SC J Appl Physiol (1985); 2003 Mar; 94(3):991-6. PubMed ID: 12391068 [TBL] [Abstract][Full Text] [Related]
6. Acetazolamide: a treatment for chronic mountain sickness. Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936 [TBL] [Abstract][Full Text] [Related]
7. Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment. Richalet JP; Rivera-Ch M; Maignan M; Privat C; Pham I; Macarlupu JL; Petitjean O; León-Velarde F Am J Respir Crit Care Med; 2008 Jun; 177(12):1370-6. PubMed ID: 18388356 [TBL] [Abstract][Full Text] [Related]
8. Respiratory control in residents at high altitude: physiology and pathophysiology. León-Velarde F; Richalet JP High Alt Med Biol; 2006; 7(2):125-37. PubMed ID: 16764526 [TBL] [Abstract][Full Text] [Related]
9. Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderate-intensity exercise. Scheuermann BW; Kowalchuk JM; Paterson DH; Cunningham DA J Appl Physiol (1985); 1999 May; 86(5):1544-51. PubMed ID: 10233116 [TBL] [Abstract][Full Text] [Related]
10. The usefulness of prophylactic use of acetazolamide in subjects with acute mountain sickness. Hung PH; Lin FC; Tsai HC; Chao HS; Chou CW; Chang SC J Chin Med Assoc; 2019 Feb; 82(2):126-132. PubMed ID: 30839503 [TBL] [Abstract][Full Text] [Related]
11. Autonomic cardiovascular function in high-altitude Andean natives with chronic mountain sickness. Keyl C; Schneider A; Gamboa A; Spicuzza L; Casiraghi N; Mori A; Ramirez RT; Leon-Velarde F; Bernardi L J Appl Physiol (1985); 2003 Jan; 94(1):213-9. PubMed ID: 12391057 [TBL] [Abstract][Full Text] [Related]
12. Selected contribution: Peripheral chemoreflex function in high-altitude natives and patients with chronic mountain sickness. Léon-Velarde F; Gamboa A; Rivera-Ch M; Palacios JA; Robbins PA J Appl Physiol (1985); 2003 Mar; 94(3):1269-78; discussion 1253-4. PubMed ID: 12571149 [TBL] [Abstract][Full Text] [Related]
13. Using modified Fenn diagrams to assess ventilatory acclimatization during ascent to high altitude: Effect of acetazolamide. Isakovich R; Cates VC; Pentz BA; Bird JD; Vanden Berg ER; de Freitas EM; Nysten CE; Leacy JK; O'Halloran KD; Brutsaert TD; Sherpa MT; Day TA Exp Physiol; 2024 Jul; 109(7):1080-1098. PubMed ID: 38747161 [TBL] [Abstract][Full Text] [Related]
14. The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects. Bashir Y; Kann M; Stradling JR Pulm Pharmacol; 1990; 3(3):151-4. PubMed ID: 2135218 [TBL] [Abstract][Full Text] [Related]
15. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Grissom CK; Roach RC; Sarnquist FH; Hackett PH Ann Intern Med; 1992 Mar; 116(6):461-5. PubMed ID: 1739236 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of the ventilatory response in subjects susceptible to high altitude pulmonary edema during acute and prolonged hypoxia. Schirlo C; Pavlicek V; Jacomet A; Gibbs JS; Koller E; Oelz O; Seebauer M; Kohl J High Alt Med Biol; 2002; 3(3):267-76. PubMed ID: 12396880 [TBL] [Abstract][Full Text] [Related]
17. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise. Jonk AM; van den Berg IP; Olfert IM; Wray DW; Arai T; Hopkins SR; Wagner PD J Physiol; 2007 Mar; 579(Pt 3):909-21. PubMed ID: 17218362 [TBL] [Abstract][Full Text] [Related]
18. Acetazolamide in control of acute mountain sickness. Lancet; 1981 Jan; 1(8213):180-3. PubMed ID: 6109857 [TBL] [Abstract][Full Text] [Related]
19. Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness. Wright AD; Beazley MF; Bradwell AR; Chesner IM; Clayton RN; Forster PJ; Hillenbrand P; Imray CH; Wilderness Environ Med; 2004; 15(1):25-31. PubMed ID: 15040503 [TBL] [Abstract][Full Text] [Related]